Traduction de «carvedilol in patients with severe chronic » (Français → Néerlandais) :

systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
16. Rouleau J, Roecker E, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.

Depuis lors, des données sur l’usage de β-bloquants chez des patients présentant une insuffisance cardiaque stable sévère, accompagnée d’un dysfonctionnement systolique ventriculaire gauche, sont disponibles: une diminution de la mortalité et du risque d’hospitalisation a ainsi été constatée à ce sujet avec le carvédilol, mais pas avec le bucindolol.
Sedertdien zijn gegevens beschikbaar gekomen over gebruik van β-blokkers bij patiënten met stabiel, ernstig hartfalen met systolische linkerventrikeldisfunctie: met carvedilol, maar niet met bucindolol, werd daarbij een daling van de mortaliteit en van het risico van hospitalisatie gezien.

- Patients atteints d’une BPCO modérée à sévère (classes 2 et 3 dans la classification de GOLD ou Global Initiative for Chronic Obstructive Lung Disease) présentant une exacerbation aiguë modérée à sévère.
- Patiënten met matig ernstige tot ernstige COPD (klassen 2 en 3 in de GOLDclassificatie; GOLD is het Global Initiative for Chronic Obstructive Lung Disease), met een matig ernstige tot ernstige acute exacerbatie.

For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several
For primary prevention of stroke, adequate blood pressure reduction, and treatment of hyperlipidemia, use of antithrombotic therapy in patients with atrial fibrillation and of antiplatelet therapy in patients with myocardial infarction are effective and supported by evidence from several randomized trials.1 Effective strategies for the secondary prevention of stroke include

27. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.
cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.

Erratum dans: CMAJ 2009; 180(10):1038. Walters JAE, Smith S, Poole PJ et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
Erratum in: CMAJ 2009; 180(10):1038 Walters JAE, Smith S, Poole PJ et al. Injectable vaccines for preventing pneumococcal infection in patiënts with chronic obstructive pulmonary disease.

of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Inhaled anticholinergics and risk of major cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

85 Fulcher, K.Y., et al. Randomised controlled trial of graded exercise in patients with the chronic fatigue
85 Fulcher, K.Y., et al. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997; 314:1647

The Beta-Blocker Evaluation of Survival Trial Investigations: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.
Naar The Beta-Blocker Evaluation of Survival Trial Investigations: A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

12. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.
of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.